- Home
- XPOF vs ZNTL Comparison
XPOF vs ZNTL Comparison
Compare XPOF & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPOF
- ZNTL
- Stock Information
- Founded
- XPOF 2017
- ZNTL 2014
- Country
- XPOF United States
- ZNTL United States
- Employees
- XPOF N/A
- ZNTL N/A
- Industry
- XPOF Services-Misc. Amusement & Recreation
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- XPOF Consumer Discretionary
- ZNTL Health Care
- Exchange
- XPOF Nasdaq
- ZNTL Nasdaq
- Market Cap
- XPOF 388.8M
- ZNTL 238.2M
- IPO Year
- XPOF 2021
- ZNTL 2020
- Fundamental
- Price
- XPOF $12.93
- ZNTL $3.12
- Analyst Decision
- XPOF Buy
- ZNTL Buy
- Analyst Count
- XPOF 10
- ZNTL 7
- Target Price
- XPOF $16.85
- ZNTL $10.86
- AVG Volume (30 Days)
- XPOF 248.5K
- ZNTL 1.2M
- Earning Date
- XPOF 11-05-2024
- ZNTL 11-04-2024
- Dividend Yield
- XPOF N/A
- ZNTL N/A
- EPS Growth
- XPOF N/A
- ZNTL N/A
- EPS
- XPOF N/A
- ZNTL N/A
- Revenue
- XPOF $326,668,000.00
- ZNTL $40,560,000.00
- Revenue This Year
- XPOF $0.85
- ZNTL N/A
- Revenue Next Year
- XPOF $9.33
- ZNTL N/A
- P/E Ratio
- XPOF N/A
- ZNTL N/A
- Revenue Growth
- XPOF 15.41
- ZNTL N/A
- 52 Week Low
- XPOF $7.40
- ZNTL $2.83
- 52 Week High
- XPOF $18.95
- ZNTL $18.24
- Technical
- Relative Strength Index (RSI)
- XPOF 52.80
- ZNTL 44.34
- Support Level
- XPOF $11.35
- ZNTL $2.92
- Resistance Level
- XPOF $12.51
- ZNTL $3.23
- Average True Range (ATR)
- XPOF 0.46
- ZNTL 0.17
- MACD
- XPOF 0.10
- ZNTL 0.00
- Stochastic Oscillator
- XPOF 90.57
- ZNTL 38.33
About XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix, a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.